NERVEVISION SOFTWARE SYSTEMS— 510(k) K121075

Name: FDA 510(k) clearance K121075
Creator: U.S. Food and Drug Administration
Published: 2012-07-26

Substantially Equivalent

3D Imaging Partners, Inc.

FDA 510(k) clearance K121075 for NERVEVISION SOFTWARE SYSTEMS, Substantially Equivalent on 2012-07-26. Applicant: 3D Imaging Partners, Inc.. Device class: 2.

Clearance details

Applicant: 3D Imaging Partners, Inc.
Product code: Code LLZ
Device class: Class 2
Regulation: 21 CFR 892.2050
Advisory panel: Radiology
Date received: 2012-04-09
Decision date: 2012-07-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bradenton, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLZ

view all

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.